Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
about
Antioxidants, inflammation and cardiovascular diseaseCholesterol: the good, the bad, and the ugly - therapeutic targets for the treatment of dyslipidemiaCholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.A "hot" topic in dyslipidemia management--"how to beat a flush": optimizing niacin tolerability to promote long-term treatment adherence and coronary disease prevention.The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults.Gene-environment interactions of CETP gene variation in a high cardiovascular risk Mediterranean populationStructure and lipid interactions of an anti-inflammatory and anti-atherogenic 10-residue class G(*) apolipoprotein J peptide using solution NMR.CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese populationApolipoprotein mimetic peptides: Mechanisms of action as anti-atherogenic agents.Integrative Treatments to Reduce Risk for Cardiovascular DiseaseAre Additional Lipid Measures Useful?Up-regulated miR-93 contributes to coronary atherosclerosis pathogenesis through targeting ABCA1.Prevalence, Predictors, and Impact of Low High-Density Lipoprotein Cholesterol on in-Hospital Outcomes Among Acute Coronary Syndrome Patients in the Middle East.A Multicenter, Prospective, Randomized, Double-blind Study to Evaluate the Safety and Efficacy of Saroglitazar 2 and 4 mg Compared to Pioglitazone 45 mg in Diabetic Dyslipidemia (PRESS V).Assessing the impact of medication use on trends in major coronary risk factors in older British men: a cohort study.Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathyEffects of Berries Consumption on Cardiovascular Risk Factors: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled TrialsCigarette smoking and interest in quitting among overweight and obese adults with serious mental illness enrolled in a fitness intervention.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritisEfficacy and safety of rosuvastatin in the management of dyslipidemiaThe Effects of Tetrahydro-iso-alpha Acids and Niacin on Monocyte-Edothelial Cell Interactions and Flow-mediated Vasodilation.Is high HDL cholesterol always good?Effects on coronary atherosclerosis by targeting low-density lipoprotein cholesterol with statins.The value and distribution of high-density lipoprotein subclass in patients with acute coronary syndrome.Caloric restriction or telmisartan control dyslipidemia and nephropathy in obese diabetic Zücker rats.Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.Associations of serum LDL particle concentration with carotid intima-media thickness and coronary artery calcification.Validation of a Newly Developed Equation for Estimating Serum Apolipoprotein B: Associations with Cardiovascular Disease Surrogate Markers in Koreans.Liver X Receptors as Therapeutic Targets for Managing Cholesterol: Implications for Atherosclerosis and Other Inflammatory ConditionsA very high prevalence of low HDL cholesterol in Spanish patients with acute coronary syndromes.Controlling lipids in a high-risk population with documented coronary artery disease for secondary prevention: are we doing enough?Recovery heart rate: an indicator of cardiovascular risk among middle school children.Lipid targets in clinical practice: successes, failures and lessons to be learned.Effect of non-oral estrogen on risk markers for metabolic syndrome in early surgically menopausal women.High-density lipoprotein cholesterol levels in middle-school children: association with cardiovascular risk factors and lifestyle behaviors.Cardiovascular Safety in Drug Development: A Role for Endothelial Function Tests.Metabolic syndrome among overweight and obese adults in Palestinian refugee camps.
P2860
Q26823009-C7C4D2A4-85FF-4FD2-B195-B17C1B58E194Q27013494-D9D74717-DC9D-4DA0-9AC6-BF5BE8D13900Q33590777-B2509B9A-8D9F-47C4-94A5-3463CD7E2AAEQ33715404-18C9B64B-CA1B-429C-9FE9-A5405D503FDFQ33765072-825FFF31-4E2B-44E4-9C9F-BF628818E283Q33993233-922D7465-832F-419D-9CA6-B5453B7E688CQ34038935-CB949B03-C769-4038-B7F9-937A309EF2EEQ34053189-FEF40553-5AB3-4DC1-AF8F-E8A13DD36468Q34384359-44966464-1D48-437C-9350-32A1AA3F3511Q34455100-AA50D550-9889-4B49-A3A2-F33087416FBEQ34594140-FDF82098-8C0B-44BA-BC94-8C1CFD627166Q34730309-02EE96ED-293E-4535-B993-597CE16D3AB3Q34730419-3F5219D4-9539-4B54-A4C5-522B9812F33CQ35173567-E26F0BF3-AEDE-49F8-A686-07AD4DF53BD6Q35228773-18633391-825C-4718-94B9-9DB8DE14DE37Q35329472-5BE9004C-AB25-4E75-B7EB-3236B5849986Q35356996-CBA94DD0-2DEC-4674-86F4-54CC4A6603B8Q35595619-B30DC4C1-02B9-4788-912B-2677D6B297F9Q36719556-3AD6C351-140D-4982-89B7-7653EE0318E6Q36852595-10C62F84-5939-462B-910C-D75C57BB3CA4Q36955395-C1A4F420-22D9-42B2-A0B3-222298161021Q37167517-FD5BDE4B-EE39-4DD8-B90A-3BCBC6DC983FQ37323896-C683504B-9325-4C71-B650-356D3791A9B7Q37351659-7C076290-AA4F-4EA4-9B8A-FB508CF8DF84Q37426672-E7E3D982-309F-4F61-83B0-48A398062895Q37509653-DFFA934D-43A1-4121-92C5-D025B9BE9924Q37532435-28A1981A-1C96-4E0D-B45C-79AE5EECCAE8Q37866321-8DF028FE-3150-43FF-ADB3-C91808FC1962Q40563244-10FDF1B4-60A4-4F36-B997-3531538E635AQ41352387-5388A908-EEEA-470E-A2AC-01A5E65520BFQ42071320-6121AB05-3998-42CB-99C7-C276BABF1575Q42966181-671A5675-21EA-4B14-A56A-E7EB03867C48Q43122651-961B264A-2F7B-46FF-B081-A3351C4310CEQ44438017-631D0011-ABC4-49B3-B757-E1A045CBB773Q45330889-661CDBEC-0E51-410E-B846-50AE926B3FADQ45933093-4ECFA4ED-19D1-4CF1-98DF-5F2F755FB036Q50763272-C6695EA3-FDB9-40C8-945C-C252659F8D32Q53139178-4D70B737-400A-4EF3-A6C1-1742FD3EE318Q55080637-1BB5E8E7-409F-4E34-A5BA-D39257626F05
P2860
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@ast
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@en
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@nl
type
label
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@ast
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@en
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@nl
prefLabel
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@ast
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@en
Targeting residual cardiovascu ...... ipoprotein cholesterol levels.
@nl
P921
P356
P1433
P1476
Targeting residual cardiovascu ...... lipoprotein cholesterol levels
@en
P2093
D M Yellon
P304
P356
10.1136/HRT.2007.125401
P407
P577
2008-06-01T00:00:00Z